Cognitive Decline and Alcohol Consumption in the Aging Population-A Longitudinal Analysis of the Survey of Health, Ageing and Retirement in Europe
Overview
Authors
Affiliations
Background: Prevalence of cognitive decline and dementia is rising globally, with more than 10 million new cases every year. These conditions cause a significant burden for individuals, their caregivers, and health care systems. As no causal treatment for dementia exists, prevention of cognitive decline is of utmost importance. Notably, alcohol is among the most significant modifiable risk factors for cognitive decline.
Methods: Longitudinal data across 15 years on 6,967 individuals of the Survey of Health, Ageing and Retirement in Europe were used to analyze the effect of alcohol consumption and further modifiable (i.e., smoking, depression, and educational obtainment) and non-modifiable risk factors (sex and age) on cognitive functioning (i.e., memory and verbal fluency). For this, a generalized estimating equation linear model was estimated for every cognitive test domain assessed.
Results: Consistent results were revealed in all three regression models: A nonlinear association between alcohol consumption and cognitive decline was found-moderate alcohol intake was associated with overall better global cognitive function than low or elevated alcohol consumption or complete abstinence. Furthermore, female sex and higher educational obtainment were associated with better cognitive function, whereas higher age and depression were associated with a decline in cognitive functioning. No significant association was found for smoking.
Conclusion: Our data indicate that alcohol use is a relevant risk factor for cognitive decline in older adults. Furthermore, evidence-based therapeutic concepts to reduce alcohol consumption exist and should be of primary interest in prevention measures considering the aging European population.
Ma L, Pang J, Liu Q, Li P, Huang J, Xu Y Front Public Health. 2025; 12:1489429.
PMID: 39741941 PMC: 11685189. DOI: 10.3389/fpubh.2024.1489429.
Alzheimer's Disease as Type 3 Diabetes: Understanding the Link and Implications.
Kciuk M, Kruczkowska W, Galeziewska J, Wanke K, Kaluzinska-Kolat Z, Aleksandrowicz M Int J Mol Sci. 2024; 25(22).
PMID: 39596023 PMC: 11593477. DOI: 10.3390/ijms252211955.
Different risk and protective factors predict change of planning ability in middle versus older age.
Unterrainer J, Petersen J, Schmidt P, Ernst M, Wirtz M, Reinwarth A Sci Rep. 2024; 14(1):25275.
PMID: 39455694 PMC: 11511955. DOI: 10.1038/s41598-024-76784-1.
Nippert K, Rowland C, Vazey E, Moorman D Neuropharmacology. 2024; 260:110114.
PMID: 39134298 PMC: 11694314. DOI: 10.1016/j.neuropharm.2024.110114.